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Rationing of health care in the United States currently exists via the covert mechanism of
restricting significant segments of medical care for many of those who cannot afford it.
Provision of universal health care would necessitate explicit rationing of certain interventions
and technologies, even though an individual could afford them. The British and Canadian
experiences provide lessons from which America can profit, and the Oregon health plan is an
experiment in this direction. The progressive "graying" of America has raised the question of
the need for intergenerational charity as aform ofrationing. The implicationsofthese rationing
planswould result in a major restructuring ofthe practice ofhematology-oncology.
Rationing has become the "buzz phrase" during any discussion of health care in
the United States. The mounting percentage of the gross national product (GNP)
which is used for medical care is now threatening other economic needs, and the
health system is portrayed as addicted to unwarranted costs and an absence ofequity
[1]. Advocates ofrationing correctly emphasize that the process already exists in the
U.S.A., where rationing on the basis of affordability now partially excludes many of
the 35 million Americans who cannot pay for medical insurance [2]. The majority of
the uninsured are women and children, although any recession, with its toll of
unemployment, consigns larger numbers ofmen to thisuninsured category.
Critics of rationing hold to a free market-open competition system as the Ameri-
canway, claiming thatmedical care shouldbe aproductwhichisbought and sold like
any other commodity. Competition in anyguise has not, however, contained medical
costs, and treating medical care as a product currently deprives many individuals of
what is considered abasichuman right in oursociety [3]. Vastlyexaggerating the cost
is the widespread assumption that physicians must do everything they believe will
benefit each patient, without any regard to costs or other societal considerations [4].
This attitude has produced the tragedy of the commons and, more specifically, as
coined by Howard Hiatt [5], the tragedy ofthe medical commons; individuals benefit
from the vast, shared technology of medicine without any strong incentive for the
individual physician to be concerned with the economic viability of the common
enterprise. Freedom ofgrazing in the medical commons may bring ruin to all, since
there is a limit to the resources which any society can devote to medical care. The
American system is the most expensive health care system in theworld, andyet avast
and growing number ofAmericans have little access to a basic level ofgood medical
care. Many feel that the uncontrolled grazing in the commons must stop. The
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combination of maldistribution and unacceptably high costs is creating increasing
acceptance of a plan for some form of a national health service in order to put a cap
on spending and to guarantee health care for all [6]. What form that health service
will take is now the subject ofmuch heated discussion in many different venues.
Any policy attempt to contain costs while maintaining effectiveness and equity in
this country considers the comprehensive strategy successfully employed by Britain
[7] and Canada [8]. Britain spends two-thirds as much money per capita in compari-
son with the U.S.A., while delivering health care to all its citizens. In Canada, with
access to medical care universal and complete, medical costs are one-third less per
capita than those in the United States; this policy results in a difference in costs of
approximately $100 billion between Canada and the U.S.A. Of additional signifi-
cance is the fact that the Canadian system has maintained a cap on health care
spending with only a 1.6 percent of the GNP increase in health care spending since
1971; the United States has increased its medical share of the GNP by 3.5 percent
during the same period [9].
These national health programs workfor Britain and Canada, but expertsquestion
their transference to the U.S.A. The high sense of responsibility for each other in
Britain and Canada is in scarce evidence in this country [10]. Another problem is that
socialized medicine in Britain has elevated the floor of medical care for all, while
accepting as the trade-off a lower ceiling of access and medical choices for the
population. This socialized medicine is unacceptable to many American physicians,
and its introduction will require a major shift in thinking to effect such a comparable
change in the United States.
These reservations need not bevoiced with respect to the Canadian health plan, a
system which has been in place for over 20 years, and which has near-universal
political and public support in that nation [11]. The plan provides socialized
insurance for hospital care and physician services; private fee-for-service reimburse-
ment to physicians continues according to a uniform schedule negotiated between
provincial medical associations and their government. Physicians in the Canadian
system are not reimbursed to the same level as their American peers, but their lives
are freed of the rationing by inconvenience which has become the albatross of
American physicians [12]. Socialized insurance as it exists in Canada, ifintroduced in
the U.S.A., would eliminate theboggling administrative costs andpaperworkparalyz-
ing the American system. Thirty to 50 billion dollars would be saved, enough to
correct the deficiency in funds forchild care thatcurrentlyexists in the United States.
Medical and lay literature suggests that the Canadian system is becoming more
attractive to Americans, although long waiting lists and unavailability of the most
modern technology echo those same deficiencies that trouble the British system.
Both systems, however, guarantee universal access to health care, a freedom not yet
in evidence in the U.S.A.
The Oregon proposal is a response to the hypocrisy of the silent rationing system
ofAmerican medicine; it is aplan toprovide access to medical care for all [13]. Since,
however, there are fiscal limits to the costs that can be assumed for health care and
because not all medical interventions areconsidered equal and effective, aprioritiza-
tion of medical interventions has been created. An 11-member health service
commission, consisting offive primary care physicians, one socialworker, one nurse,
and five consumers, has ranked medical services according to theirexpectedbenefits,
which include quality of life and compassion, in addition to curing of disease. The
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legislature must establish the budget available to fund health care and decide the
percentage of available tax-generated assets which can be used for health care,
schools, environment, and so on. This proposal has forced the citizens ofthe state to
develop an overall health policy for the state and to decide how much money health
care can demand. A ceiling isbeing placed on runaway health expenditures. Doctors
will continue to do everything for their patients but only for those services included
under the priority inclusion criteria. The fact that the Oregon proposal is being
initiated to handle the Medicaid population of Oregon has led its critics to fault this
experiment as being one conducted disproportionately on poor patients, who are
predominantly women and children [14]. The exclusion of a young leukemic child
from access to a bone marrow transplant (BMT) has also generated much negative
publicity for an admittedly two-tiered medical system [15]. Its advocates maintain
that very expensive medical care must give way to wiser use of resources, that the
costs of BMT and other transplants could be better applied to preventive care,
especially in the prenatal realm [16]. Of note is the fact that the rationing is
determined by the citizenry and not by physicians, and a health plan will be in place
that should permit savings in some aspects ofcare to be applied to improvements in
others [171-a major deficiency in the present medical setting and a major deterrent
to anycost consciousness in the individual doctor-patient relationship (DPR).
These government-imposed health plans in Britain, Canada, and Oregon, if
implemented in the U.S.A., would impose a medical change which involved physi-
ciansand health insurersbutwould not demand anybasic alterationinthe consumer-
patient's attitudes regarding use of health care resources. The philosopher, Daniel
Callahan [18], and, similarly, Larry Churchill [19], a theologian, believe that it must
beotherwise; theycontend that a fundamental shift inAmericans'pursuitoflimitless
medical progress and "having it all" in health care must take place. Callahan
implicates the World Health Organization (WHO) definition of health-a state of
complete physical, mental, and social well-being-as a cause of our need to have
every health care met and every evidence of mortality challenged. This unrealistic
quest, coupled with the advertisement of patient autonomy as the most important
component of the DPR, has vitiated any consensus on health care priorities which
would allow us to live within our means. Callahan believes the American health care
system is addicted touncontainable costs and that noformofincreased efficiencywill
hold down those costs [20]. This addiction has its source in our enchantment with
technology, which is always supplanted by newer, and frequently more expensive,
technologies. Callahan uses the metaphor ofthe ragged edge ofmedical progress-
needs are constantlyredefined-escalating andexpanding. Ifanynewtherapyortool
isbeneficial, it mustbe afforded, or at least itought tobe. To correct thismisdirected
quest, Callahan calls not only for rationing ofmedical care and stringent assessment
of technological advances before dissemination, but he endorses a rationing of
medical progress, a sacrificing ofpotentially beneficial advances that must be passed
over on the basis of costs. The artificial heart has no place in Callahan's scheme.
The most controversial aspect of Callahan's rationing suggestions, however,
focuses upon the progressive graying of America and the intensification of services
that medical progress is adding to their care [18]. He suggests cost containment by
explicit rationing, using age as a criterion-this approach requires that Americans
accept death as the end of a natural life span and that they substitute communalism
for selfish individualism. Each citizen would benefit over the course of his or her
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lifetime ifmoney, used to extend life at its end, were redirected to an earlier stage of
life; in his most idealized schema, intergenerational charity would constitute part of
anyvirtuous society. Callahan would also not fund medical research or the develop-
ment ofhealth care directed at extending life. HisSettingLimits has, not surprisingly,
unsettled the elderly and their defenders in our society. Callahan has been accused
of perpetuating American society's emphasis on youth. But, in his defense, he has
offered a solution which is not without precedent and parallels the surge of the
movement of death with dignity. He is joined in his conclusion by Prof. Leon Kass,
who defends the concept of a natural life span and castigates as a perversion the
medical attempts at needlessly prolonging life [21]. Callahan's dicta arose from a
bioethicist's concern with equity and costs; Kass's observations evolve out of his
deliberations on the proper end ofmedicine as a noble calling.
Intergenerational charity, communalism, and a rejection of medical progress,
specifically in the service of the elderly [22], do not appear as immediate options to
resolve the problems of the U.S. health care system. Review of hospital cost
containment in the 1980s leads experts to conclude that the real excesses have
already been eliminated and that whatever further reduction will be achieved will
only result in a limited and transient effect on costs [23]. The shift to the ambulatory
setting in medical care is offsetting any major gain in savings on inpatient care.
Marcia Angell looks to revision of fee schedules, which now favor performance of
expensive procedures, to reverse the trend ofrising costs; the relative resource value
scale should be in place by 1992 to better reimburse the cognitive aspects, while
reimbursinglesswell the procedural components ofmedical care. Systematic studies
are already under way to assess the effectiveness of medical technologies and
practices in the U.S.A.-this research is long overdue in a countrywhere the relative
numberofangioplastiesperformed is 11 times the numberperformed in Britain [24].
But any major reduction in health care costs must primarily involve the physician,
sincephysicians determine amajorpercentage ofhealth care costs [25]. Expectations
that individual physicianswill police the use ofresources in the care oftheir patients
are unrealistic. A strong current in the profession still supports the position that the
patient must remain the doctor's master in matters of obtaining all of the best
treatment for that patient [4]. Savings will only be possible if external standards or
restraints are imposed-if a system is inplace that oversees the allocation ofmedical
resources. The shape and outline of that system are still in the future, but it may be
helpful to explore how rationing of various sorts would affect the practice of
hematology-oncology and how the particular problems ofthis specialty might throw
some light upon the problems and solutions ofrationing.
Aaron and Schwartz in their book, The Painful Prescription [7], have compared
treatment of cancer patients in the United States and Britain-they document a
striking disparity in medical spending forchemotherapy in the two countries. Britain
spent approximately 18 million dollars on such drugs in 1981, about 70 percent less
than the U.S. on a population-corrected basis. The total cost ofchemotherapy in the
United States during the same period was 900 million dollars. The reasons for the
difference in treatment costs are not attributable to the costs of the drugs, the
method offinancing treatment, or external restraints on the British physician; at the
same time, hemophilia patients were provided the same care in both countries. The
major reason for the disparity in spending for cancer drugs is physician-imposed-
British physicians believe that palliative treatment of incurable solid tumors is
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squandering large sums of money on ineffective treatment. They do not expose
patients with renal, lung, metastatic colon cancer, or melanoma to chemotherapy,
although they do treat breast and prostatic carcinoma as vigorously as their Ameri-
can counterparts. The relatively reduced numbers ofoncologists in Britainversus the
U.S. also keeps a cap on any excessive distribution ofthe funds. Aaron and Schwartz
believe, however, that British physicians, under the restraints of their health care
system, find medical reasons to withhold expensive care from their patients. They
stop, set limits, where marginal benefits equal marginal costs. This attitude is in
dramatic contrast to American medical care, where treatments are used until they
provide no additional payoffs [26]. The British system has forced physicians to ration
oncologic care, and without any real difference in outcome-its linkage with social-
ized medicine should not blind American physicians to avoid assuming the same
stance, but the American public will need convincing of this non-interventional
posture. British containment of cost by physicians is realized by recognizing the
marginal benefits ofmany interventions inoncology andbyexcludingthose therapies
which are not curative. Patients with incurable malignancies in the U.S.A. might still
desire or demand chemotherapy [27], a situation which could be resolved by
requiring that all such patients enter experimental protocols. Any expenditures
would thereby contribute to the common fund of knowledge in identifying those
novel therapies which are curative. The means whereby these restraints could be
introduced might issue from controls imposed by the Society of American Oncolo-
gists, a posture guaranteed to rankle many members of the society.
The Canadian system has successfully held in check progressive escalation in
health costs by restraining administrative costs, physician fees, and the intensity of
servicing in hospitals [28]; it has also marshalled funds from private sources to
purchase expensive diagnostic machinery such as computed tomography scanners.
American critics of the system point out the long waiting lists, the unavailability of
some modern technology, and the depreciation ofthe physical plant as drawbacks of
Canadian medicine. An example ofthis type ofdifficulty is the nearunavailability of
hemodialysis units to treat renal failure; however, the cheaper alternative ofchronic
ambulatory peritoneal dialysis is readily available for all in need of dialysis treat-
ments [29]. In Canada, costs are contained by such limiting of the options in
technology and, in one ofthe provinces, Quebec, monitoring and limiting individual
physician expenditures. The Canadians deny that there is any real difference in
accessibility to medical care in their country as compared with the U.S.; the denial is
based on their definition of accessibility as the ability ofpeople to get not only care
which they need, but care that is likely to improve their health. The definition may
vary fromprovince to province, but the system isresponsive andmalleable, especially
when there is any orchestrated outrage to effect changes. Health policy experts in
Canada also anticipate that there will be a progressive squeeze on acute hospital
beds, forcing physicians to alter their use of this resource. The Canadian system is
therefore causing physicians at several levels-technology/bed use/reimburse-
ment-to consider the effect ofoutcome on health care.
This change has important implications for American hematologists-oncologists
not only in the previously mentioned use ofchemotherapeutic agents but in the use
of expensive resources for many cancer patients near the ends of their lives. A
commendable effort by an American subspecialty group, the pulmonologists, exam-
ined the proper use of mechanical ventilation [30] by looking at the outcome of
79THOMAS P. DUFFY
patients with carcinoma who required ventilator assistance. Of those 180 patients
with malignancies who were intubated, only 26 percent survived to extubation; 13
percent were alive at two months and 7 percent at six months; a second group
documented that only four of 52 patients with tumors who received mechanical
ventilation left the hospital; one of 23 oncology patients with granulocytopenia
survived the trauma of this intervention. Such dismal outcomes should force the
hematology-oncologycommunity to examine its use ofthese scarce resources and to
considerwhether intensive care units are likely to improve the health of the majority
ofthesepatients[31]. Our currentsystem has no mechanism in place to establish any
policyorguidelines inresponse to these statistics. The Canadian system is envisioned
as one which will eventually examine these priorities and curtail the use of marginal
interventions.
The Oregon proposal represents one state's attempt to control health care costs
[32]-its initial prioritization scheme eliminated all organ transplants, apart from
renal and corneal transplants, for the Medicaid population. After two adults were
denied organ transplants, the Oregon policy received nationwide attention for
denying a BMT to a seven-year-old boy with acute leukemia [15]. The designers of
the plan defended their stance bypointing out that the projected cost of 2.2 million
dollars for treatment of 34 such patients could extend medical coverage for 1,500
persons not previously covered for medical care. A new prioritization scheme has
been established, and it will be interesting to see how the $300,000 cost of a liver
transplant will be handled-an intervention now covered by Medicare for the aged.
Critics of the Oregon policy's stance regarding transplant unavailability believe
thatorgan transplantation, a successful therapy, has been unfairly excluded from the
Medicaid menu; they suggest that endarterectomies and coronary artery bypass
procedures should be foregone because of their lesser proven efficacy in restoring
health. But the current use of BMT for treatment of a whole host of solid tumors
could jeopardize the entire funding structure of any health plan. It remains an
experimental therapy for metastatic breast cancer, and yet courts are forcing third
parties to underwrite the costs of this intervention. This decision is the most recent
example in oncology of dissemination into the community of unproven treatments
without the efficacy of such interventions having been established by good clinical
trials. The insurance companies are funding just such a trial in metastatic breast
cancer-thistype offunding,by thegovernment or insurance companies, will pay for
itself in reducing fees for unsubstantiated procedures and treatments. A marrow
transplantmight well fallwithinOregon'spriorityfunding ifits efficacy is proven and
other futile interventions are eliminated from the scale [33].
The final form of rationing, of setting limits according to Daniel Callahan, has
especial reverberations in the field ofhematology-oncology when one considers the
management of acute leukemia in the aged. The prognosis with such an illness was
once sopoor thatchemotherapywas not offered to individuals over age 60 with acute
leukemia [34]. With better success in inducing remissions in the sixth decade of life,
this therapy is now offered to individuals with little attention to age, although
increased ageconveys asignificantlypoorerprognosis in this disease [35]. Leukemia
treatment requires at least an initial one-month hospitalization under extreme
duress, andthe cost oftherapyforoneyearoftreatment is$150,000 to $200,000. Less
than 50 percent of elderly patients with acute leukemia will obtain a complete
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remission, and the remission will last an average ofonly 12 months; there isvirtually
no chance ofleukemia cure in this age group.
This instance represents the concrete situation which Callahan forces our society
and the profession to address-leukemia treatment in the aged is not absolutely
futile, but large amounts ofmoney and resources are being used at an extreme oflife
to prolong life of questionable quality. Is this a defensible situation in which setting
limits by age is appropriate, or is any attempt at rationing care on the basis of age
unacceptable? Our society may echo the response of Admetus's parents in Eurip-
ides' playAlcestis, when Admetus asked them to sacrifice their lives for his own-
"God's daylight is sweet even to the old. We do not askyou to die for us; we will not
die for you." Admetus replied with angry contempt; "You, standing palsied at the
gate ofdeath andyet afraid to die" [36].
No current rationing system is without its problems nor its critics [37]. But the
suggestions andplansinprogress haveforcedpeople torecognize theproblem and to
open the dialogue. Most efforts at any explicit rationing or national health plan have
been resisted and even sabotaged by the medical community. The atmosphere now
appears different, and the outcome of the current dialogue should have a major
contributionfromphysicians. There ismuch to learn from the British, Canadian, and
Oregon plans and much to ponder in the gauntlet thrown down by Daniel Callahan
and his colleagues. Formal rationing, whether by physicians, insurance companies,
the government, or some other agency, will soon be integral to the practice of
medicine inAmerica [38].
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